Overview

A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)

Status:
Completed

Trial end date:
2020-06-02

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy of a tocilizumab-based regimen compared with placebo on top of rapidly tapered glucocorticoid treatment in a double- blind, controlled fashion, focussing on glucocorticoid-free remission of disease.

Phase:

Phase 3

Details

Lead Sponsor:

Medical University of Vienna

Treatments:

Glucocorticoids